id,nct_id,allocation,intervention_model,observational_model,primary_purpose,time_perspective,masking,masking_description,intervention_model_description,subject_masked,caregiver_masked,investigator_masked,outcomes_assessor_masked
93307064,NCT06030869,,,COHORT,,PROSPECTIVE,,,,,,,
93307065,NCT02534727,,,COHORT,,PROSPECTIVE,,,,,,,
93523475,NCT03634033,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,SINGLE,,Main Study: Randomized 2-Arms. Administrative Supplement: Cohort (Pilot) Study.,False,False,False,True
93307066,NCT01163539,,,ECOLOGIC_OR_COMMUNITY,,PROSPECTIVE,,,,,,,
93307067,NCT01642043,,,COHORT,,PROSPECTIVE,,,,,,,
93307068,NCT02549417,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307069,NCT02779348,RANDOMIZED,CROSSOVER,,TREATMENT,,NONE,,,,,,
93307070,NCT03225898,RANDOMIZED,CROSSOVER,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93307071,NCT06326879,,,COHORT,,PROSPECTIVE,,,,,,,
93307072,NCT06080360,,,CASE_ONLY,,CROSS_SECTIONAL,,,,,,,
93307073,NCT05571826,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93307074,NCT01026298,RANDOMIZED,CROSSOVER,,PREVENTION,,NONE,,,,,,
93307075,NCT03264690,,,COHORT,,PROSPECTIVE,,,,,,,
93307076,NCT03575949,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93307077,NCT00263497,NON_RANDOMIZED,CROSSOVER,,TREATMENT,,NONE,,,,,,
93307078,NCT00000469,RANDOMIZED,,,PREVENTION,,DOUBLE,,,,,,
93307079,NCT02077205,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307080,NCT04718311,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307081,NCT04698746,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93307082,NCT00043069,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,DOUBLE,,,True,False,True,False
93307083,NCT02059356,,,COHORT,,PROSPECTIVE,,,,,,,
93307084,NCT02772328,RANDOMIZED,PARALLEL,,SCREENING,,DOUBLE,,,False,False,True,True
93307085,NCT04303507,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,True,False
93307086,NCT03898700,NA,SINGLE_GROUP,,OTHER,,NONE,,Pre-post coaching intervention,,,,
93307087,NCT01788475,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307088,NCT02555553,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307089,NCT02295176,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93307090,NCT03718377,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307091,NCT02472002,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307092,NCT01071603,,,,,PROSPECTIVE,,,,,,,
93307093,NCT02061878,RANDOMIZED,PARALLEL,,,,TRIPLE,,,True,False,True,True
93307094,NCT03132662,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307095,NCT02274779,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091114,NCT01475877,,,,,PROSPECTIVE,,,,,,,
93091115,NCT05532865,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93307096,NCT06385184,,,CASE_CONTROL,,CROSS_SECTIONAL,,,,,,,
93307097,NCT03126071,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307098,NCT04292964,,,COHORT,,RETROSPECTIVE,,,,,,,
93307099,NCT01333553,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091116,NCT04380506,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307100,NCT00688220,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93307101,NCT05996367,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307102,NCT03006185,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,DOUBLE,,,False,False,True,True
93307103,NCT02169557,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091117,NCT01609348,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,True,False
93091118,NCT03042117,,,CASE_CONTROL,,CROSS_SECTIONAL,,,,,,,
93091119,NCT05062122,,,COHORT,,OTHER,,,,,,,
93307104,NCT01468077,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307105,NCT04520568,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,SINGLE,,,True,False,False,False
93307106,NCT04058470,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414897,NCT04951882,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307107,NCT01450293,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,False,False,False,True
93307108,NCT05347017,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307109,NCT05879003,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307110,NCT03430544,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307111,NCT03243240,,,CASE_ONLY,,CROSS_SECTIONAL,,,,,,,
93307112,NCT01928693,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,True,False
93307113,NCT00925392,RANDOMIZED,SINGLE_GROUP,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93307114,NCT04349007,RANDOMIZED,PARALLEL,,OTHER,,SINGLE,Single (Investigator),,False,False,True,False
93307115,NCT04519593,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,Patients who meet study inclusion criteria will be randomized into one of two treatment arms: 1) laparoscopic myomectomy preceded by temporary uterine blood supply occlusion or 2) laparoscopic myomectomy with a conventional approach.,,,,
93414898,NCT00715780,,,COHORT,,PROSPECTIVE,,,,,,,
93414899,NCT06154044,NA,SINGLE_GROUP,,TREATMENT,,NONE,Imaging core lab employees will be blinded to the patient's status (before or after cell therapy),,,,,
93087009,NCT03532126,,,COHORT,,PROSPECTIVE,,,,,,,
93087010,NCT01081262,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091120,NCT06453408,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93091121,NCT04849208,,,OTHER,,OTHER,,,,,,,
93091122,NCT00058396,,,,TREATMENT,,NONE,,,,,,
93307116,NCT01434680,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,False,False,True,False
93307117,NCT01012245,,,COHORT,,PROSPECTIVE,,,,,,,
93307118,NCT02515006,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93307119,NCT02551211,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93307120,NCT03947008,RANDOMIZED,PARALLEL,,OTHER,,NONE,,"The proposed pilot study will evaluate the feasibility and acceptability of an intuitive eating program for University of Delaware college women. A randomized controlled design will be used to study the effects of an intuitive eating intervention on body dissatisfaction and dietary restraint in young adult women, thereby reducing risk of eating disorders. There will be 2 arms of this study. The First Intuitive Eating Group (IE1) will act as the intervention group and receive the intervention first. The Second Intuitive Eating Group (IE2) will act as a waitlist group and receive the intervention the week immediately following the end of IE1's course.",,,,
93307121,NCT04682782,RANDOMIZED,CROSSOVER,,TREATMENT,,TRIPLE,,,True,True,True,False
93307122,NCT06330935,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307123,NCT04429282,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,,,True,True,True,True
93307124,NCT03414528,,,FAMILY_BASED,,PROSPECTIVE,,,,,,,
93307125,NCT02939339,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307126,NCT03930329,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,False,False,False,True
93091123,NCT04617782,RANDOMIZED,CROSSOVER,,OTHER,,NONE,open label,"Phase 1, open-label, randomized, 3-period, 3-treatment, crossover PK study to evaluate the steady-state pharmacokinetics",,,,
93091124,NCT05481775,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091125,NCT01650298,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,NONE,,,,,,
93523476,NCT05619653,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,Placebo,"multicentre randomised double-blind, placebo-controlled clinical trial 1:1 randomisation",True,True,True,True
93091126,NCT00028483,,,,TREATMENT,,,,,,,,
93091127,NCT05599308,NON_RANDOMIZED,PARALLEL,,SCREENING,,NONE,,"Prospective, parallel-cohort, open label, non-randomized study",,,,
93091128,NCT03689582,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091129,NCT03762876,,,COHORT,,PROSPECTIVE,,,,,,,
93091130,NCT05697783,,,COHORT,,RETROSPECTIVE,,,,,,,
93091131,NCT02204930,NA,SINGLE_GROUP,,SUPPORTIVE_CARE,,NONE,,,,,,
93091132,NCT04412577,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091133,NCT01138423,RANDOMIZED,CROSSOVER,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091134,NCT01412177,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93091135,NCT06343831,NA,SINGLE_GROUP,,OTHER,,NONE,,"Patients planning to undergo autologous fat transfer for breast or chest wall reconstruction will be enrolled prospectively. Participants will undergo standard photographs (2-D imaging) of their chest wall and torso, including the breasts, and complete a validated questionnaire (BREAST-QTM) to evaluate patient satisfaction, and quality of life, all standard of care. The 3D photographs, MRI, and US are routinely used in practice but will be performed for research purposes in this study.",,,,
93091136,NCT04772872,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091137,NCT03991312,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091138,NCT02038816,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091139,NCT03367767,,,COHORT,,PROSPECTIVE,,,,,,,
93091140,NCT01391364,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091141,NCT02085759,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091142,NCT01026545,RANDOMIZED,PARALLEL,,,,DOUBLE,,,True,False,True,False
93091143,NCT00008008,,,,TREATMENT,,NONE,,,,,,
93307127,NCT03693053,,,COHORT,,PROSPECTIVE,,,,,,,
93307128,NCT00525928,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307129,NCT01561482,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93523477,NCT02823821,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93523478,NCT03735992,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93523479,NCT06524115,NA,SINGLE_GROUP,,SCREENING,,NONE,,,,,,
93091144,NCT00683878,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091145,NCT00923923,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,DOUBLE,,,True,False,True,False
93091146,NCT06048302,NON_RANDOMIZED,PARALLEL,,OTHER,,NONE,,"This is a Phase 1, open-label, single-dose, parallel-group study to evaluate the plasma PK and safety of obicetrapib in participants with moderate hepatic impairment relative to participants with normal hepatic function. The purpose of the study is to investigate the effect of moderate hepatic impairment on obicetrapib PK and safety in otherwise healthy participants after a single oral 10 mg dose of obicetrapib.",,,,
93091147,NCT02041325,RANDOMIZED,PARALLEL,,,,DOUBLE,,,True,False,True,False
93091148,NCT03397264,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,Ph 1b open label; Ph 2a quadruple masked,Phase 1b - sequential dose followed by Phase 2a - parallel arm,True,True,True,True
93091149,NCT02682381,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,TRIPLE,,,True,True,True,False
93091150,NCT03481894,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93091151,NCT00060645,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307130,NCT05801445,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307131,NCT03167151,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307132,NCT00709501,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93307133,NCT05730114,,,COHORT,,PROSPECTIVE,,,,,,,
93307134,NCT01021709,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414900,NCT05078476,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93523480,NCT05299398,RANDOMIZED,PARALLEL,,PREVENTION,,TRIPLE,,,True,True,True,False
93523481,NCT03197467,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93523482,NCT06354920,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,Quasi-experimental randomized controlled trial,,,,
93523483,NCT06346847,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,"Randomized, Double-blind, Placebo-controlled",True,True,True,False
93543873,NCT03297866,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93087011,NCT04383457,,,COHORT,,PROSPECTIVE,,,,,,,
93087012,NCT04690530,,,COHORT,,PROSPECTIVE,,,,,,,
93087013,NCT06283771,RANDOMIZED,CROSSOVER,,OTHER,,TRIPLE,"An independent biostatistician, who is not involved in the study, will select 70 individuals from the list of students enrolled between 1-250 by computer-generated randomization. The information that the volunteers included in the research sample were assigned to group A (experimental) and B (control) according to the randomization table will be kept by the researcher and the socks with the same appearance, with and without heating feature will be numbered from 1 to 70 according to the randomization table and given to the researcher. Thus, the practitioner will be blinded as he/she does not know which sock has a heating feature and which one does not. Healthy volunteers will be blinded because they do not know which group they are in. The data will be analyzed by a statistician independent of the research and the findings will be reported. Thus, the data analysis and statistics phase will also be blinded to group assignment.","The research was planned as a prospective, two-arm (1:1), randomized controlled, double-blind study",True,False,True,True
93087014,NCT01960582,NON_RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93087015,NCT04376749,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93087016,NCT04961541,RANDOMIZED,PARALLEL,,PREVENTION,,TRIPLE,,,True,True,True,False
93087017,NCT03939637,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93087018,NCT01684202,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087019,NCT00191308,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087020,NCT00664885,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93087021,NCT06583629,NA,SINGLE_GROUP,,SUPPORTIVE_CARE,,NONE,,,,,,
93087022,NCT01433172,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93087023,NCT00640107,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93087024,NCT01843023,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93087025,NCT02451995,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307135,NCT01382498,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,,,True,True,True,True
93307136,NCT03553381,,,COHORT,,PROSPECTIVE,,,,,,,
93307137,NCT01076244,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307138,NCT01156740,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307139,NCT03024892,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307140,NCT03049670,,,COHORT,,PROSPECTIVE,,,,,,,
93307141,NCT00304382,RANDOMIZED,CROSSOVER,,PREVENTION,,NONE,,,,,,
93307142,NCT05828758,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,"Enrolled children will be equally randomized into study and control group using computer generated numbers, which will be sealed into sequentially numbered opaque envelopes by a person not belonging to the research team. For each enrolled participant, the envelope in order will be opened, and the assigned study drug will be used. A pharmacist will fill the active and placebo preparations in similar containers with sealed code for identification. Participants' families, treating clinicians, and investigators will be unaware of group assignment and drug/placebo therapy.","Two groups of children with enteral feeding intolerance:

Study group: will receive amoxicillin 10 mg/kg (50 mg/ml concentration) by nasogastric tube 3 times daily (8 hours apart) 10 minutes before bolus gastric feeding for 7 days. The nasogastric tube will be flushed by 5 ml distilled water after each dose.

Control group: will receive equal volume of distilled water (0.2 ml/kg + 5 ml) as a placebo.",True,True,True,True
93307143,NCT04351698,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307144,NCT03832972,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93307145,NCT02939846,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307146,NCT04243057,,,OTHER,,OTHER,,,,,,,
93307147,NCT01780454,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307148,NCT00161369,,,DEFINED_POPULATION,,PROSPECTIVE,,,,,,,
93307149,NCT01421212,NA,SINGLE_GROUP,,PREVENTION,,NONE,,,,,,
93307150,NCT03186586,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,True,False
93307151,NCT04030689,,,OTHER,,OTHER,,,,,,,
93307152,NCT00648687,RANDOMIZED,PARALLEL,,PREVENTION,,TRIPLE,,,False,True,True,True
93307153,NCT05889949,,,COHORT,,PROSPECTIVE,,,,,,,
93307154,NCT03437941,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307155,NCT02274077,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307156,NCT06011278,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,SINGLE,,"Assignment to the experimental and control groups will be made by an independent statistician to avoid bias and ensure confidentiality. Thus, selection bias will be controlled by making random assignment and hiding the randomization.

In the study, participant and researcher will not be blinded. Blinding will not be possible because the researcher follows the participants and parents on a daily basis and is aware of the intervention. The data will be coded as 'A' and 'B' by the researcher and transferred to the computer. It is recommended that all stages of randomized controlled trials be conducted according to the Consolidated Standards of Reporting Trials (CONSORT). In this context, the study will be conducted on the basis of the CONSORT 2017 (Updated Guidelines for Reporting Randomized Parallel Group Studies) guideline during the randomization stages of this study.",False,False,False,True
93307157,NCT01265043,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307158,NCT06074692,NON_RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307159,NCT04636645,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93307160,NCT03560570,,,CASE_CONTROL,,RETROSPECTIVE,,,,,,,
93307161,NCT05202756,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307162,NCT05194163,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,Subjects will be randomized through a computerized system by a Data/Statistics Group independent from the investigator or Sponsor,double-blind randomized placebo-controlled,True,True,True,True
93307163,NCT04515056,RANDOMIZED,SINGLE_GROUP,,BASIC_SCIENCE,,SINGLE,,,True,False,False,False
93307164,NCT02561208,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93307165,NCT01579643,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307166,NCT01758705,,,COHORT,,PROSPECTIVE,,,,,,,
93307167,NCT06269159,,,COHORT,,OTHER,,,,,,,
93307168,NCT01271504,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307169,NCT03865953,RANDOMIZED,CROSSOVER,,TREATMENT,,QUADRUPLE,,"This is the first study with LAT8881 in subjects with neuropathic pain. As such, it has been designed to evaluate, in a well-defined patient group, the concept that LAT8881 is safe and effective in this indication.

Subjects enrolled into this study have been diagnosed with Post Herpetic Neuralgia (PHN) or Diabetic Peripheral Neuropathy (DPN), both conditions being well accepted examples of neuropathic pain. Because the pain is chronic, without a period effect, and treatment is symptomatic rather than curative, a crossover study is considered appropriate. Studies with other agents have successfully demonstrated analgesic effects in PHN and DPN with a crossover study design",True,True,True,True
93307170,NCT00882115,NA,SINGLE_GROUP,,BASIC_SCIENCE,,NONE,,,,,,
93307171,NCT00981708,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307172,NCT05828836,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307173,NCT02375347,NA,SINGLE_GROUP,,,,NONE,,,,,,
93307174,NCT02412579,,,COHORT,,PROSPECTIVE,,,,,,,
93307175,NCT05147337,RANDOMIZED,PARALLEL,,OTHER,,DOUBLE,,,True,False,True,False
93307176,NCT01547598,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,True,False
93307177,NCT00415701,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307178,NCT03017937,NA,SINGLE_GROUP,,OTHER,,NONE,,,,,,
93307179,NCT03313141,NA,SINGLE_GROUP,,BASIC_SCIENCE,,NONE,,To compare diaphragm elastrography provided by ultrasound to diaphragm function indices provided by magnetic/electrical phrenic nerves stimulation,,,,
93307180,NCT02706951,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93473197,NCT03123978,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307181,NCT03653923,RANDOMIZED,CROSSOVER,,BASIC_SCIENCE,,NONE,Psychotherapeutic Investigation - No masking possible,"Waiting-List RCT with crossover after Treatment (Waiting-List will be treated, treated subjects will rest)",,,,
93307182,NCT01855347,,,COHORT,,PROSPECTIVE,,,,,,,
93473198,NCT00111956,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93473199,NCT06256835,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,DOUBLE,,,False,False,True,True
93473200,NCT00347113,RANDOMIZED,SINGLE_GROUP,,PREVENTION,,NONE,,,,,,
93473201,NCT01888341,RANDOMIZED,CROSSOVER,,TREATMENT,,NONE,,,,,,
93473202,NCT01502124,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93473203,NCT03836924,,,COHORT,,PROSPECTIVE,,,,,,,
93473204,NCT03534908,,,COHORT,,RETROSPECTIVE,,,,,,,
93307183,NCT01908751,RANDOMIZED,FACTORIAL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93523484,NCT05201144,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,Study drug/placebo will be drawn up in amber syringes by investigational pharmacy to blind the bedside RN who will be administering the study drug. Only investigational pharmacy is unblinded.,"randomized, double blinded, placebo controlled pilot trial",True,True,True,True
93307184,NCT04292587,,,COHORT,,PROSPECTIVE,,,,,,,
93307185,NCT01821105,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93307186,NCT01475461,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,True,False
93307187,NCT04594837,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307188,NCT00508495,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307189,NCT03509389,,,COHORT,,PROSPECTIVE,,,,,,,
93307190,NCT04740723,NA,SINGLE_GROUP,,DEVICE_FEASIBILITY,,NONE,,"The study is a prospective, single-arm, multi-center, non-randomized feasibility trial",,,,
93307191,NCT00571441,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93307192,NCT03080142,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307193,NCT06544356,,,OTHER,,CROSS_SECTIONAL,,,,,,,
93307194,NCT02328079,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307195,NCT03946202,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414901,NCT04331314,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,Twenty patients scheduled for lateral-window sinus floor Elevation SFE will be randomized to an HA and a Î²-TCP/HA Group.,True,False,True,False
93414902,NCT00876902,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,True,False
93414903,NCT04071249,,,COHORT,,PROSPECTIVE,,,,,,,
93523485,NCT04104412,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93523486,NCT04323618,NA,SINGLE_GROUP,,DEVICE_FEASIBILITY,,NONE,,,,,,
93523487,NCT05342753,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93523488,NCT06069154,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,"All investigators, participants, and clinical staff will be masked to treatment group assignment, with the only exception being the unmasked individual who performs the procedure (and will not have subsequent contact with the participant).","Pragmatic, multicenter, randomized, triple-masked, sham-controlled clinical trial",True,True,True,True
93523489,NCT05441033,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,No masking was applied. Both participants and researchers were aware of the assigned interventions.,"Randomized controlled trial with three parallel arms: fetal heart sounds group (FHS), guided imagery technique group (GIT), and control group.",,,,
93523490,NCT04602026,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93523491,NCT06847906,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,SINGLE,,Compare two different types of a virtual CDS tool in a randomized pilot study at one health system.,True,False,False,False
93523492,NCT04236414,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93523493,NCT02984566,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93523494,NCT03848663,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93523495,NCT05199194,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93523496,NCT03805451,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93523497,NCT04865406,,,COHORT,,PROSPECTIVE,,,,,,,
93523498,NCT03243344,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,False,True,False,False
93523499,NCT01632904,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93523500,NCT01045083,RANDOMIZED,CROSSOVER,,DIAGNOSTIC,,SINGLE,,,False,False,False,True
93523501,NCT04721704,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93523502,NCT05709119,,,COHORT,,PROSPECTIVE,,,,,,,
93523503,NCT03958214,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,All interviews are conducted by research assistants who are blind to study condition.,Families are blocked within home visitor caseload and randomly assigned to receive the new curriculum or usual practice Early Head Start home visits for 12 weeks.,False,False,False,True
93307196,NCT01632189,NA,SINGLE_GROUP,,BASIC_SCIENCE,,NONE,,,,,,
93307197,NCT01896180,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307198,NCT01112436,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93307199,NCT00520624,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,True,False
93307200,NCT02002962,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307201,NCT04812743,NA,SINGLE_GROUP,,PREVENTION,,NONE,,,,,,
93307202,NCT03496077,RANDOMIZED,CROSSOVER,,OTHER,,NONE,,Randomized cross-over study,,,,
93307203,NCT05896189,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,False,True
93307204,NCT00532168,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307205,NCT05465759,,,COHORT,,RETROSPECTIVE,,,,,,,
93307206,NCT02804321,,,COHORT,,PROSPECTIVE,,,,,,,
93307207,NCT06026475,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,Participant will be masked about allotment of interventional group either CVP or SVV .,"Patients in Conventional Group will be given intraoperative fluids guided by CVP Values .

Patients in GDFT Group will be given fluids guided by SVV values.",True,False,False,False
93307208,NCT03019081,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93307209,NCT01626508,,,COHORT,,PROSPECTIVE,,,,,,,
93307210,NCT02167919,NA,SINGLE_GROUP,,DEVICE_FEASIBILITY,,NONE,,,,,,
93307211,NCT02205775,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307212,NCT01013545,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93307213,NCT03943017,,,OTHER,,PROSPECTIVE,,,,,,,
93307214,NCT01144962,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93414904,NCT01376115,,,COHORT,,PROSPECTIVE,,,,,,,
93414905,NCT02207127,,,COHORT,,PROSPECTIVE,,,,,,,
93414906,NCT03622294,NA,SINGLE_GROUP,,SUPPORTIVE_CARE,,NONE,,"Participants will be female, asymptomatic patients randomly scheduled for a screening mammogram.",,,,
93414907,NCT00400504,,,DEFINED_POPULATION,,PROSPECTIVE,,,,,,,
93414908,NCT03463980,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93414909,NCT04543526,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93414910,NCT01078389,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93523504,NCT00077441,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93523505,NCT00663897,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93523506,NCT01668953,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93523507,NCT02819245,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93543874,NCT01553565,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307215,NCT05488288,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307216,NCT05046925,,,OTHER,,PROSPECTIVE,,,,,,,
93307217,NCT00364377,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93307218,NCT00822770,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307219,NCT00621205,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,NONE,,,,,,
93307220,NCT05069298,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,False,True
93307221,NCT03894319,,,COHORT,,PROSPECTIVE,,,,,,,
93307222,NCT01772563,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307223,NCT02542098,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307224,NCT00565838,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93307225,NCT05075512,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307226,NCT05779917,NA,SINGLE_GROUP,,TREATMENT,,NONE,,Use engineered CAR-T cells to kill cancer cells with mesothelin overexpression.,,,,
93307227,NCT04817605,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307228,NCT00244647,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,SINGLE,,,,,,
93307229,NCT01427049,,,COHORT,,PROSPECTIVE,,,,,,,
93307230,NCT05666817,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,SINGLE,2,"The study will be conducted with 76 women, 38 controls and 38 interventions.",True,False,False,False
93307231,NCT01192776,RANDOMIZED,FACTORIAL,,TREATMENT,,NONE,,,,,,
93307232,NCT00736125,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,True,False,False,False
93307233,NCT04374383,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93307234,NCT01859611,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307235,NCT04908306,,,COHORT,,PROSPECTIVE,,,,,,,
93307236,NCT01408810,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307237,NCT00136110,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,,,,
93307238,NCT05833659,,,COHORT,,OTHER,,,,,,,
93307239,NCT03349411,,,COHORT,,PROSPECTIVE,,,,,,,
93307240,NCT00000983,,,,TREATMENT,,,,,,,,
93307241,NCT01371071,,,COHORT,,PROSPECTIVE,,,,,,,
93307242,NCT00385307,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93307243,NCT03251612,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307244,NCT02719041,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93307245,NCT02045290,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307246,NCT01938313,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307247,NCT03790904,RANDOMIZED,CROSSOVER,,PREVENTION,,QUADRUPLE,,,True,True,True,True
93307248,NCT04885647,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414911,NCT02615665,,,COHORT,,RETROSPECTIVE,,,,,,,
93414912,NCT01917565,,,CASE_CROSSOVER,,CROSS_SECTIONAL,,,,,,,
93414913,NCT00643331,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307249,NCT00019695,,,,TREATMENT,,,,,,,,
93307250,NCT00890799,NA,SINGLE_GROUP,,TREATMENT,,SINGLE,,,True,False,False,False
93414914,NCT01002573,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414915,NCT01579240,NA,SINGLE_GROUP,,PREVENTION,,NONE,,,,,,
93414916,NCT02249273,,,COHORT,,PROSPECTIVE,,,,,,,
93414917,NCT05457712,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,"Due to the nature of the intervention, full blinding will not be possible. However, the statistical analysis team will be blinded.","Randomized clinical trial, pragmatic, with blind evaluation of outcomes.",False,False,False,True
93414918,NCT02812823,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93414919,NCT01454895,RANDOMIZED,FACTORIAL,,PREVENTION,,NONE,,,,,,
93414920,NCT03377218,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,,,True,True,True,True
93414921,NCT04622059,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,NONE,,,,,,
93414922,NCT02286206,NA,SINGLE_GROUP,,OTHER,,NONE,,,,,,
93414923,NCT03518307,,,OTHER,,RETROSPECTIVE,,,,,,,
93414924,NCT00133276,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,True,False
93414925,NCT06401902,,,COHORT,,PROSPECTIVE,,,,,,,
93199282,NCT01728792,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93307251,NCT05350488,,,COHORT,,OTHER,,,,,,,
93307252,NCT00060437,,,,TREATMENT,,NONE,,,,,,
93307253,NCT02632812,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307254,NCT05762419,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307255,NCT00342537,,,FAMILY_BASED,,OTHER,,,,,,,
93307256,NCT05399368,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,Double blind,,True,False,True,True
93307257,NCT01130649,,,OTHER,,OTHER,,,,,,,
93307258,NCT04044703,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307259,NCT01854307,NA,SINGLE_GROUP,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93307260,NCT02602483,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307261,NCT06300983,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93307262,NCT05426993,,,COHORT,,PROSPECTIVE,,,,,,,
93307263,NCT01486368,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307264,NCT02486419,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93307265,NCT03913169,NON_RANDOMIZED,SINGLE_GROUP,,HEALTH_SERVICES_RESEARCH,,NONE,,The intervention utilized in this project will involve a 2-year curriculum. The year one/pre-clinical curriculum will be presented to pre-clinical DO and PA students. The year two/clinical curriculum will be presented to third year Doctor of Osteopathic Medicine (DO) students and second year Physician Assistant (PA) students once clinic sites are identified.,,,,
93307266,NCT04457817,,,COHORT,,PROSPECTIVE,,,,,,,
93307267,NCT03531554,RANDOMIZED,CROSSOVER,,OTHER,,DOUBLE,"Double (Participant, Outcomes Assessor)","randomized, blinded, placebo controlled, 2-way cross-over trial",True,False,False,True
93307268,NCT03045809,,,OTHER,,CROSS_SECTIONAL,,,,,,,
93307269,NCT01617499,,,COHORT,,PROSPECTIVE,,,,,,,
93307270,NCT01341249,RANDOMIZED,CROSSOVER,,,,NONE,,,,,,
93307271,NCT01182064,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93307272,NCT05132855,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,True,False,False,False
93414926,NCT01973673,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93414927,NCT04823494,NON_RANDOMIZED,CROSSOVER,,TREATMENT,,DOUBLE,,,True,True,False,False
93414928,NCT02789761,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,True,False
93414929,NCT04114227,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93414930,NCT03618576,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414931,NCT05645731,,,COHORT,,PROSPECTIVE,,,,,,,
93414932,NCT05584917,NA,SINGLE_GROUP,,SUPPORTIVE_CARE,,NONE,,,,,,
93307273,NCT01253447,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307274,NCT03177200,,,COHORT,,PROSPECTIVE,,,,,,,
93307275,NCT01860547,RANDOMIZED,CROSSOVER,,PREVENTION,,NONE,,,,,,
93307276,NCT05085561,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,True,False
93307277,NCT00171795,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,,,,
93307278,NCT03552640,,,OTHER,,PROSPECTIVE,,,,,,,
93307279,NCT00227123,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307280,NCT00510900,,,COHORT,,PROSPECTIVE,,,,,,,
93307281,NCT04011293,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307282,NCT00754598,NON_RANDOMIZED,,,DIAGNOSTIC,,,,,,,,
93307283,NCT05364034,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307284,NCT05480462,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,True,False,False,False
93307285,NCT03137706,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93307286,NCT01447199,,,FAMILY_BASED,,PROSPECTIVE,,,,,,,
93307287,NCT06210061,RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93307288,NCT00394420,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307289,NCT00672282,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,True,False
93307290,NCT03000348,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307291,NCT00134771,RANDOMIZED,PARALLEL,,ECT,,DOUBLE,,,,,,
93307292,NCT01390441,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307293,NCT04486599,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307294,NCT01380977,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,False,False,True,True
93307295,NCT06029608,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93307296,NCT04901845,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93307297,NCT01514955,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,,,,,,,
93307298,NCT04581252,,,COHORT,,PROSPECTIVE,,,,,,,
93307299,NCT05592977,NA,SINGLE_GROUP,,TREATMENT,,NONE,"Due to the nature of the study, the operator and patients can't be blinded. Blinding of the outcome assessors can be done by sealing the name of the patient in the pre and post treatment radiographs used for analysis",,,,,
93307300,NCT00752245,RANDOMIZED,CROSSOVER,,TREATMENT,,NONE,,,,,,
93307301,NCT00004072,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307302,NCT02111408,,,COHORT,,PROSPECTIVE,,,,,,,
93307303,NCT03980197,RANDOMIZED,CROSSOVER,,PREVENTION,,NONE,,,,,,
93307304,NCT02484989,,,,,PROSPECTIVE,,,,,,,
93307305,NCT04458818,NA,SINGLE_GROUP,,TREATMENT,,NONE,"No Masking. Patients in one arm are provided with prolene mesh implant, and is known by the patient, health care provider and the assessor.","The single group will be implanted with Prolene mesh made into Swiss rolls and placed in Laryngeal Window between the cartilage and inner periosteum,",,,,
93307306,NCT00085566,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307307,NCT00296010,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307308,NCT03672942,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,SINGLE,couples are not informed as to what condition they are assigned,random assignment to two active conditions vs. a placebo control,True,False,False,False
93307309,NCT01367444,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307310,NCT03174782,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,"To randomize patients, consent forms will be pre-labeled with a random subject identification number. This number will serve as the participants' study ID for all data collection in order to maintain privacy and confidentiality. Additionally, this number will be linked to a sealed envelope containing the random treatment group. The study coordinator will create the labels and assemble the envelopes to ensure all investigators remain blind to the treatment groups. This sealed envelope will be given to the anesthesia providers for the amputation. The anesthesia team will then administer the assigned treatment prior to induction of general anesthesia. Half of the patients will be randomized into the treatment group, and half of the patients will be randomized into the control group.",,True,True,True,False
93414933,NCT03102541,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93307311,NCT06140342,,,OTHER,,PROSPECTIVE,,,,,,,
93307312,NCT05379153,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,DOUBLE,The provider will not be blinded to the arm the patient is on. PRO measures will be administered by research personnel who are blinded to the arm the patient is enrolled on at each study time point.,,True,False,False,True
93199283,NCT02080182,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307313,NCT00184379,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414934,NCT01401179,RANDOMIZED,FACTORIAL,,TREATMENT,,SINGLE,,,False,False,False,True
93307314,NCT04805073,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,Stratified randomization design,,True,True,True,False
93307315,NCT03178045,,,COHORT,,PROSPECTIVE,,,,,,,
93307316,NCT05196451,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,SINGLE,,,False,False,False,True
93307317,NCT03995342,RANDOMIZED,PARALLEL,,OTHER,,DOUBLE,,,True,False,True,False
93307318,NCT01078922,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307319,NCT02706847,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307320,NCT02595320,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307321,NCT01854606,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307322,NCT00085397,RANDOMIZED,,,TREATMENT,,,,,,,,
93307323,NCT00746304,,,COHORT,,RETROSPECTIVE,,,,,,,
93307324,NCT01980004,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93307325,NCT01587482,,,COHORT,,PROSPECTIVE,,,,,,,
93307326,NCT00003477,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307327,NCT03375736,NA,SINGLE_GROUP,,TREATMENT,,NONE,,"The study participants would receive 4 weeks of whole body vibration therapy, 4 sessions per week for 18 minutes per session.",,,,
93414935,NCT00205010,,,,,PROSPECTIVE,,,,,,,
93414936,NCT02623569,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93414937,NCT01265719,,,COHORT,,PROSPECTIVE,,,,,,,
93414938,NCT04411316,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414939,NCT03604016,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414940,NCT06388538,,,COHORT,,PROSPECTIVE,,,,,,,
93414941,NCT06369402,,,CASE_CONTROL,,CROSS_SECTIONAL,,,,,,,
93414942,NCT03981523,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,Three of 6 parallel groups will receive one of three different oral benznidazole (BZN) dosing regimens and the other three will receive one of the three different nifurtimox (NFX) regimens.,,,,
93414943,NCT03846895,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93414944,NCT02831595,,,COHORT,,PROSPECTIVE,,,,,,,
93199284,NCT02542839,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,False,True
93091152,NCT03636659,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091153,NCT01772446,RANDOMIZED,PARALLEL,,,,NONE,,,,,,
93091154,NCT00197314,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,,,,
93091155,NCT05844891,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,SINGLE,"Research assistants conducting telephone follow-up assessments 3, 6, 9, and 12 months after enrollment will be blinded to group allocation.",,False,False,False,True
93091156,NCT03006380,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,False,True
93091157,NCT03789916,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091158,NCT05394519,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091159,NCT06094608,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,"The outcomes assessor will be blinded to study arm. The PI, study coordinator and research assistants will remain unblinded to perform safety assessments and provide feedback on intervention adherence. Blinded staff will wear buttons as an upfront visual cue to remind participants not to talk about their treatment.",,False,False,False,True
93091160,NCT05686785,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93091161,NCT05877755,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091162,NCT05084313,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,"There are three groups in the study, two of which includes interventions, and one group constitutes the control group. The participants will be randomized into groups with a sealed envelope. There is only one session of the allocated intervention for the particular participant, since the study aims to measure acute effects of cranial and visceral manual therapy on autonomic nervous system parameters.",,,,
93091163,NCT04149249,RANDOMIZED,PARALLEL,,OTHER,,SINGLE,,,True,False,False,False
93091164,NCT00363532,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,SINGLE,,,,,,
93091165,NCT05228665,NA,SINGLE_GROUP,,TREATMENT,,NONE,,Prospective cohort,,,,
93091166,NCT00463255,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091167,NCT02018341,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,DOUBLE,,,True,False,True,False
93091168,NCT05133024,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,"Beetroot juice bottles are delivered at the central investigational site in labeled boxes indicating whether they are active or control juice. The bottles themselves are identical in appearance and only distinguishable by the manufacturer through the production code. Blinding of the juices is done by an independent party who is responsible for removing the labels, indicating whether the juices are active or nitrate-depleted juice, from the boxes, and assigning an intervention letter code to active or control beetroot juice as 'A' or 'B', without revealing which is which. Sets of 7 bottles, corresponding with the dosage regimen, from A or B according to the randomization list made by an independent statistician, are then labelled with an unique randomization letter code comprising of 2 randomly generated letters, followed by an underscore and a numerical index from 1 to 7 (e.g. AX_1,..., AX_7) to assure allocation concealment.",Multicentric double-blind randomized controlled prospective phase II study,True,True,True,True
93091169,NCT04098523,NA,SINGLE_GROUP,,SCREENING,,NONE,,,,,,
93091170,NCT05801991,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091171,NCT01998750,,,COHORT,,PROSPECTIVE,,,,,,,
93091172,NCT03985241,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091173,NCT06308822,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091174,NCT00421798,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091175,NCT01757314,,,COHORT,,PROSPECTIVE,,,,,,,
93091176,NCT04057066,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091177,NCT04354792,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93091178,NCT04956536,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93091179,NCT04796597,NA,SEQUENTIAL,,DEVICE_FEASIBILITY,,NONE,,,,,,
93091180,NCT01057953,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091181,NCT00547274,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091182,NCT03016312,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091183,NCT03088891,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,TRIPLE,,,True,False,True,True
93091184,NCT00467077,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091185,NCT00900510,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091186,NCT01840007,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091187,NCT01089686,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,TRIPLE,,,True,True,False,True
93091188,NCT02539004,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091189,NCT05010811,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93091190,NCT02454738,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091191,NCT02356445,,,COHORT,,RETROSPECTIVE,,,,,,,
93091192,NCT05982990,RANDOMIZED,CROSSOVER,,OTHER,,SINGLE,laboratory-blinded,"One-center crossover, randomized, 2-period, 2-sequence (RT and TR), single dose, laboratory-blinded study",False,False,False,True
93091193,NCT01239069,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,True,False
93091194,NCT00190437,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091195,NCT00963963,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091196,NCT02916966,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091197,NCT04759235,,,COHORT,,PROSPECTIVE,,,,,,,
93091198,NCT03210935,,,COHORT,,PROSPECTIVE,,,,,,,
93091199,NCT04416568,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091200,NCT00472225,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091201,NCT06392724,NA,SINGLE_GROUP,,TREATMENT,,NONE,,"Single-arm unblinded, single-center study",,,,
93091202,NCT01316523,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091203,NCT00138749,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,,,,
93091204,NCT01178463,,,COHORT,,RETROSPECTIVE,,,,,,,
93091205,NCT01451723,NON_RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091206,NCT00922623,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091207,NCT04814966,,,OTHER,,OTHER,,,,,,,
93091208,NCT04897217,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091209,NCT02773186,,,,,PROSPECTIVE,,,,,,,
93091210,NCT00665665,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091211,NCT01366872,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93091212,NCT02932137,RANDOMIZED,CROSSOVER,,PREVENTION,,NONE,,,,,,
93091213,NCT00911248,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091214,NCT02372578,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93091215,NCT03967145,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091216,NCT06275334,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93091217,NCT02732457,,,COHORT,,PROSPECTIVE,,,,,,,
93091218,NCT06071949,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091219,NCT03300401,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93318796,NCT04865133,,,CASE_ONLY,,OTHER,,,,,,,
93087026,NCT03008694,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091220,NCT02208102,,,COHORT,,PROSPECTIVE,,,,,,,
93091221,NCT04233008,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,Randomized controlled trial,,,,
93091222,NCT01331603,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091223,NCT03546985,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93091224,NCT00182130,RANDOMIZED,SINGLE_GROUP,,ECT,,NONE,,,,,,
93091225,NCT01062750,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091226,NCT02793336,,,COHORT,,PROSPECTIVE,,,,,,,
93091227,NCT03777358,,,COHORT,,PROSPECTIVE,,,,,,,
93091228,NCT04118465,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091229,NCT02123134,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091230,NCT04415203,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93091231,NCT00768989,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091232,NCT03729648,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,"Due to the nature of this trial, neither the staff, participants nor care provider can be masked to allocation. The data analyst will be blinded after study completion by having the intervention group information coded.",Parallel Randomized Controlled Trial,False,False,True,False
93091233,NCT06275555,RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93091234,NCT02867267,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091235,NCT01635231,RANDOMIZED,CROSSOVER,,DIAGNOSTIC,,TRIPLE,,,True,True,True,False
93091236,NCT03921658,,,COHORT,,PROSPECTIVE,,,,,,,
93091237,NCT00726947,NON_RANDOMIZED,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091238,NCT03431441,NA,SINGLE_GROUP,,TREATMENT,,NONE,"Due to visible print differences, subjects and investigators will be aware of the patterns/variants of the investigational product. However, subjects will be masked to the lens brand to prevent bias during the lens discussions.",,,,,
93091239,NCT01866371,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091240,NCT06001346,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,False,False,True,True
93091241,NCT03290443,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091242,NCT04049708,,,COHORT,,PROSPECTIVE,,,,,,,
93091243,NCT00989001,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091244,NCT02919644,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091245,NCT00657540,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091246,NCT05020509,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93091247,NCT03726489,RANDOMIZED,PARALLEL,,OTHER,,NONE,,"Pragmatic, randomized, active comparator effectiveness study",,,,
93091248,NCT02655029,,,COHORT,,PROSPECTIVE,,,,,,,
93091249,NCT03908333,NA,SINGLE_GROUP,,TREATMENT,,NONE,,Ascorbic Acid Paclitaxel Protein Bound Cisplatin Gemcitabine,,,,
93091250,NCT01067378,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,SINGLE,,,True,False,False,False
93091251,NCT03714178,NA,SINGLE_GROUP,,TREATMENT,,NONE,,Patients undergoing catheter ablation of paroxysmal atrial fibrillation and meeting all protocol inclusion/exclusion criteria will be treated with the FARAPULSE Endocardial Ablation System.,,,,
93091252,NCT00468026,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091253,NCT00509184,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091254,NCT03296917,RANDOMIZED,PARALLEL,,PREVENTION,,TRIPLE,,,True,True,True,False
93091255,NCT03909893,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091256,NCT00242671,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,,,,
93091257,NCT06208553,NA,SINGLE_GROUP,,HEALTH_SERVICES_RESEARCH,,NONE,Patient and clinician outcome measures are self-reported and therefore not blinded to study phase. Chart auditors will not be blinded to study phase.,Single phase (step) of larger stepped-wedge cluster randomized trial design in which 3-month baseline period serves as pre-test after which implementation intervention is introduced (intervention phase) and then post-test data collected (similar to time series design).,,,,
93091258,NCT02134223,RANDOMIZED,CROSSOVER,,OTHER,,SINGLE,,,False,False,False,True
93091259,NCT04781010,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091260,NCT04985929,RANDOMIZED,CROSSOVER,,BASIC_SCIENCE,,TRIPLE,"Double-blind, placebo-controlled","Randomized, double-blind, placebo-controlled cross-over design",True,True,True,False
93091261,NCT03684863,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091262,NCT01077635,,,COHORT,,PROSPECTIVE,,,,,,,
93091263,NCT05979740,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091264,NCT00178477,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091265,NCT01198197,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091266,NCT01466608,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091267,NCT05681650,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091268,NCT05750251,,,OTHER,,PROSPECTIVE,,,,,,,
93091269,NCT02043938,NA,SINGLE_GROUP,,OTHER,,NONE,,,,,,
93091270,NCT02724358,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091271,NCT04507607,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93091272,NCT04718623,,,COHORT,,PROSPECTIVE,,,,,,,
93091273,NCT03202407,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,single blinded,parallel group,True,False,False,False
93091274,NCT02810613,,,OTHER,,OTHER,,,,,,,
93091275,NCT02339311,,,COHORT,,PROSPECTIVE,,,,,,,
93091276,NCT01107951,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091277,NCT06000124,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,All subjects were randomly assigned to either the control or experimental group to receive their respective exercise programs. The outcomes assessor was blinded to the group allocation of each participant during baseline and post-intervention assessments. No group assignment information was provided to the care providers.,"The experimental group underwent plyometric training three times a week, performing three rounds each session, for a total intervention period of 10 weeks. The control group, on the other hand, engaged in regular exercises during the same intervention period. Before and after the training program, both groups underwent assessments to evaluate their balance abilities, which included the 30-second sit-to-stand test, time up and go test (TUG), functional reach test (FRT), and lower extremity explosiveness test.",False,True,False,True
93091278,NCT03200119,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93116906,NCT05637060,RANDOMIZED,CROSSOVER,,OTHER,,NONE,Only Analysts will be kept blind,"A single center, open label, randomized, single-dose, two period, two-way, cross-over study. Subjects will receive one single dose per treatment period separated by a wash-out period of 7 days.",,,,
93116907,NCT04215965,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307328,NCT04088929,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307329,NCT04237285,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,SINGLE,,,False,False,False,True
93307330,NCT03376750,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,three-arm randomized control trail (RCT) including pre/post intervention and follow-up,False,False,True,True
93307331,NCT01502592,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307332,NCT04610411,RANDOMIZED,SEQUENTIAL,,TREATMENT,,SINGLE,,,True,False,False,False
93091279,NCT05583487,NON_RANDOMIZED,SINGLE_GROUP,,OTHER,,SINGLE,All teams will be asked to progressively mobilize the ventilated neurosurgery patient they are assigned to during the shift. Each team will be blinded to whether or not they will be utilizing the nurse-led mobility protocol or standard mobility procedures until arrival at the patient's room during the assigned mobility time.,"This study will consist of a quasi-experimental research design to examine causality between two or more variables by comparing groups following an intervention. Although the intervention itself will be randomly assigned/administered to each of the multidisciplinary groups for this proposed research study, true randomization of participants cannot be achieved. This is primarily due to each patient having a pre-assigned multidisciplinary care team for each shift. Changing this patient assignment would compromise patient safety while interfering with continuity of care and workflow, which hospital units strive to achieve. By applying the purpose and elements of a quasi-experimental approach to this proposed research study, researchers can determine if an intervention/active independent variable consisting of a nurse-led mobility protocol, has an effect on the outcome measure of teamwork perceptions , which will serve as dependent variables.",False,True,False,False
93414945,NCT01205464,RANDOMIZED,CROSSOVER,,BASIC_SCIENCE,,TRIPLE,,,True,True,True,False
93414946,NCT05829018,NON_RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,SINGLE,,Cross-sectional study,True,False,False,False
93091280,NCT02271698,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091281,NCT05297877,RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93091282,NCT01458639,NON_RANDOMIZED,CROSSOVER,,DIAGNOSTIC,,SINGLE,,,False,False,False,True
93091283,NCT01038141,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091284,NCT05182788,RANDOMIZED,PARALLEL,,OTHER,,DOUBLE,,,True,False,True,False
93091285,NCT00301795,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091286,NCT01169129,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091287,NCT02870998,NON_RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93091288,NCT03779542,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091289,NCT03900507,,,COHORT,,PROSPECTIVE,,,,,,,
93091290,NCT00317993,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,DOUBLE,,,,,,
93091291,NCT06527170,,,COHORT,,PROSPECTIVE,,,,,,,
93091292,NCT02230735,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,DOUBLE,,,True,False,True,False
93091293,NCT01906333,RANDOMIZED,CROSSOVER,,,,NONE,,,,,,
93091294,NCT06118437,,,OTHER,,PROSPECTIVE,,,,,,,
93091295,NCT01149317,NON_RANDOMIZED,SINGLE_GROUP,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93091296,NCT01262807,RANDOMIZED,SINGLE_GROUP,,PREVENTION,,SINGLE,,,False,False,False,True
93091297,NCT01222013,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091298,NCT04458506,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93091299,NCT01582815,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091300,NCT06181526,RANDOMIZED,SEQUENTIAL,,TREATMENT,,DOUBLE,,"In this study, a dose-escalation clinical trial is conducted to explore the maximum tolerated dose, and three dose groups are set: 0.5 Î¼g/kg, 1 Î¼g/kg, and 2 Î¼g/kg, with 3 cases in the initial dose group and placebo group, and 6 cases in the follow-up dose group, with a total of 24 subjects.",True,False,True,False
93091301,NCT05524467,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93091302,NCT00866177,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091303,NCT05161897,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091304,NCT05852834,,,OTHER,,CROSS_SECTIONAL,,,,,,,
93091305,NCT03798106,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091306,NCT04622111,RANDOMIZED,SEQUENTIAL,,TREATMENT,,DOUBLE,Only PART B will be double-blind,,True,False,True,False
93091307,NCT06381804,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93091308,NCT04072926,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,Each of the two main groups are divided to two subgroups.,True,False,False,False
93091309,NCT03921749,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,"group A : focused shock wave, group B: focused shock wave",True,False,True,True
93091310,NCT03549975,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091311,NCT02745197,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,QUADRUPLE,,,True,True,True,True
93091312,NCT05101447,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091313,NCT03092583,NON_RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,NONE,,,,,,
93091314,NCT06019624,NON_RANDOMIZED,SEQUENTIAL,,PREVENTION,,NONE,,,,,,
93091315,NCT01793428,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091316,NCT06528366,RANDOMIZED,CROSSOVER,,TREATMENT,,DOUBLE,"The research includes the responsible researcher, assistant and collaborator. The Collaborating Researcher is responsible for applying the technique to the patient not knowing which stimulus will be true or sham. He must apply the research tools and fill out de forms. The Collaborating Researcher should alert the Main Researcher and Assistant Research if regards signs or symptoms in patient resulting adverse effects.

In this way, the patient and the Collaborating Researcher are blinding.","Crossover Study Experimental Group Hospital phase (Group 1): Patients will receive 3mA current for 20 minutes with anodal stimulation through HD-tDCS (4x1) with 5 sessions on 5 consecutive days and before the surgical procedure.

Control Group (2) Sham: Patients receive the simulated HD-tDCS anodic current (4x1) with 3mA that accelerates for 30 seconds and decelerates for another 30 seconds, 5 sessions on 5 consecutive days and before the surgical procedure .

Washout period - surgery and recovery for discharge (on average 15 days). Experimental Group Outpatient phase (Group 1) - active for Chlorella pyrenoidosa - consume 10 tablets per day of Chlorella p for 30 days. (5g/day) and must return within 30 days for evaluation.

Control Group 2 - will not consumption of Chlorella pyrenoidosa and must return within 30 days for evaluation.",True,True,False,False
93091317,NCT02220257,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091318,NCT02834481,NA,SINGLE_GROUP,,SUPPORTIVE_CARE,,NONE,,,,,,
93091319,NCT03917849,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091320,NCT00143910,,,COHORT,,PROSPECTIVE,,,,,,,
93091321,NCT05011227,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091322,NCT04059549,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93307333,NCT00267098,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93307334,NCT02768350,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93091323,NCT04676295,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091324,NCT01754974,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091325,NCT02663011,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93091326,NCT00611689,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091327,NCT00003239,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091328,NCT02678351,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091329,NCT05354908,,,CASE_ONLY,,CROSS_SECTIONAL,,,,,,,
93091330,NCT03195816,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,Comparison between experimental group and control group.,True,False,False,True
93091331,NCT02707068,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93091332,NCT00741052,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091333,NCT01919229,RANDOMIZED,PARALLEL,,,,NONE,,,,,,
93091334,NCT04509700,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091335,NCT03242629,RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93091336,NCT01011673,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091337,NCT05513352,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,TRIPLE,single-blind,"Experiment 1:

* between-subject design
* 3x4 = 3(hearing group) x 4(condition)
* Masking: Single (Participant)
* Masking Description: single-blind

Experiment 2:

* between-subject design
* 3x4 = 3(hearing group) x 4(condition)
* Masking: Single (Participant)
* Masking Description: single-blind

Experiment 3:

* between-subject design
* 3x2x2x4 = 3(hearing group) x 2 (stimulation) x 2(timepoint) x 4(condition)
* Masking: Double (Participant, investigator)
* Masking Description: double-blind

Experiment 4:

* between-subject design
* 3x2x2x4 = 3(hearing group) x 2 (stimulation) x 2(timepoint) x 4(condition)
* Masking: Double (Participant, investigator)
* Masking Description: double-blind

Experiment 5:

* within-subject design
* 2x2x4 = 2 (training) x 2(timepoint) x 4(condition)
* Masking: Double (Participant, investigator)
* Masking Description: double-blind

Primary Purpose: Basic Science",True,True,False,True
93091338,NCT05553795,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,Randomized controlled multicentric trial,,,,
93091339,NCT00420576,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93091340,NCT03225235,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091341,NCT03168620,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,SINGLE,,,False,False,False,True
93091342,NCT06021639,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,SINGLE,Randomization will be planned 1 to 1 according to the order of application. Randomization will be planned by the endoscopy nurse in the endoscopy unit and will not be known to the endoscopist who will perform the procedure.,"Clear diet group (72 patients) 250 ml Sennozit A+B calcium (half dose is taken orally at 17.00 on the day before the procedure and the other half at 19.00 will be consumed. Enema 210 cc (Monobasic sodium phosphate 28.5 g. Dibasic sodium phosphate 10.5 g.) The procedure is rectal at 07.00 in the morning. will be used as Routine feeding of the patient up to the last 24 hours before the procedure. The last 24 hours will consume clear diet.

Low fiber diet group (72 patients) 250 ml Sennozit A+B calcium (half dose is taken orally at 17.00 on the day before the procedure and the other half at 19.00 will be consumed. Enema 210 cc (Monobasic sodium phosphate 28.5 g. Dibasic sodium phosphate 10.5 g.) The procedure is rectal at 07.00 in the morning. will be used as Routine feeding of the patient up to the last 24 hours before the procedure. He/she will consume low fiber food in the last 24 hours.",False,False,True,False
93091343,NCT04486235,RANDOMIZED,PARALLEL,,OTHER,,NONE,The condition of the participant is revealed after the participant completes the consent form and screening questionnaire and is deemed eligible.,"Randomization is stratified. On the screening form, participants indicate whether or not they plan to speak with their physician about their weight in their appointment. Randomization is stratified by if if the participant indicates that they plan to speak about weight or not.",,,,
93091344,NCT05591092,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091345,NCT05543954,NON_RANDOMIZED,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091346,NCT00626275,RANDOMIZED,CROSSOVER,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091347,NCT01998022,,,,,PROSPECTIVE,,,,,,,
93091348,NCT04916574,NON_RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091349,NCT06020157,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93091350,NCT02052804,,,COHORT,,PROSPECTIVE,,,,,,,
93091351,NCT03563820,,,COHORT,,PROSPECTIVE,,,,,,,
93091352,NCT00531258,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93091353,NCT04283071,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091354,NCT05534074,,,COHORT,,OTHER,,,,,,,
93091355,NCT00898963,,,OTHER,,RETROSPECTIVE,,,,,,,
93091356,NCT03507036,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091357,NCT00468299,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091358,NCT01562080,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091359,NCT02604381,RANDOMIZED,PARALLEL,,OTHER,,TRIPLE,,,True,False,True,True
93091360,NCT03833739,RANDOMIZED,PARALLEL,,TREATMENT,,,,Randomized clinical trial,,,,
93091361,NCT00504088,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091362,NCT01092728,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091363,NCT01788566,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091364,NCT04748666,RANDOMIZED,FACTORIAL,,TREATMENT,,NONE,,"The investigators will compare a) care partner emotional symptom (depression) change and b) caregiver burden change from baseline to 6-months post-baseline, to assessed long-term effects of PST and booster sessions several months beyond completion of the training. The investigators will also measure secondary care partner outcomes, including caregiver self-efficacy, positive aspects of caregiving, and alcohol use. Finally, the investigators will assess care partners' satisfaction, confidence using the PST strategy, and engagement across all conditions.",,,,
93091365,NCT04053608,,,COHORT,,PROSPECTIVE,,,,,,,
93091366,NCT01544426,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93091367,NCT00370123,,,COHORT,,PROSPECTIVE,,,,,,,
93091368,NCT00329888,,,DEFINED_POPULATION,,OTHER,,,,,,,
93091369,NCT01527968,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091370,NCT04139226,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414947,NCT03031613,RANDOMIZED,PARALLEL,,PREVENTION,,TRIPLE,,,True,True,False,True
93414948,NCT03051906,NA,SINGLE_GROUP,,TREATMENT,,NONE,Open label,,,,,
93414949,NCT03672136,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414950,NCT02114736,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93414951,NCT00627913,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93414952,NCT00957736,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93414953,NCT02563964,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93307335,NCT02580747,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091371,NCT00339586,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307336,NCT05196971,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93307337,NCT05834868,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307338,NCT02777645,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93087027,NCT00190723,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087028,NCT02067936,RANDOMIZED,PARALLEL,,,,TRIPLE,,,True,True,True,False
93091372,NCT05973734,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,All patients are planned to receive an islet transplantation. The patients will also receive either Arm 1) recipient T regulatory cell infusion or arm 2) same donor vertebral body derived bone marrow cell infusion. Attribution to either arm will be based on the availability of either cell product in specific cases.,,,,
93091373,NCT02643459,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091374,NCT04392726,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93091375,NCT05022186,RANDOMIZED,CROSSOVER,,TREATMENT,,TRIPLE,,,False,True,True,True
93091376,NCT02232217,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93091377,NCT04370158,,,COHORT,,PROSPECTIVE,,,,,,,
93091378,NCT00764439,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091379,NCT04761978,,,COHORT,,RETROSPECTIVE,,,,,,,
93091380,NCT02489071,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,SINGLE,,,False,False,False,True
93091381,NCT04959747,RANDOMIZED,CROSSOVER,,TREATMENT,,SINGLE,"Subjects of both groups will be randomly assigned into 2 groups, the acupuncture group or the control (sham) acupuncture group with 1:1 ratio. For randomization, simple, complete non-sequential random numbers will be generated in advance by a computer program in a block of four, and kept by the principal investigator. After a patient's eligibility is confirmed, a randomization number which corresponds to the group allocation will be provided to the acupuncturist by the PI. This arrangement will ensure that the clinical assessor and participants are blinded to the allocation.","single blinded, randomized sham controlled, cross-over clinical trial",True,False,False,False
93091382,NCT03075618,,,COHORT,,PROSPECTIVE,,,,,,,
93091383,NCT00721396,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091384,NCT03170726,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091385,NCT00371592,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,True,False,False
93091386,NCT02633670,RANDOMIZED,FACTORIAL,,TREATMENT,,SINGLE,,,True,False,False,False
93091387,NCT00744926,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091388,NCT04827108,,,OTHER,,CROSS_SECTIONAL,,,,,,,
93091389,NCT01473290,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,DOUBLE,,,,,,
93091390,NCT06461663,NA,SINGLE_GROUP,,TREATMENT,,NONE,,All subjects will undergo breast conserving surgery with the BCL.,,,,
93091391,NCT04079426,,,OTHER,,PROSPECTIVE,,,,,,,
93091392,NCT06150950,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,"At enrollment, participants will be randomized in a 1:1 ratio to cardiac rehabilitation or usual care using randomly permuted blocks of 2, 4, and 6. The randomization will be stratified by study site and time from Fontan palliation.",,,,
93091393,NCT03167333,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091394,NCT03178383,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,True,False,False,False
93091395,NCT05262257,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93091396,NCT05003037,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091397,NCT02749539,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93091398,NCT04647201,,,COHORT,,RETROSPECTIVE,,,,,,,
93091399,NCT02696265,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091400,NCT02867735,NA,SEQUENTIAL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091401,NCT02464618,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93091402,NCT04731389,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93091403,NCT01338337,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091404,NCT03775798,,,COHORT,,PROSPECTIVE,,,,,,,
93091405,NCT05505448,RANDOMIZED,SEQUENTIAL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091406,NCT01658748,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091407,NCT04107714,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091408,NCT02414308,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087029,NCT05984043,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93087030,NCT01522300,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93087031,NCT01819155,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,,,True,True,True,True
93087032,NCT00821496,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087033,NCT05370131,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,DOUBLE,,,False,False,True,True
93091409,NCT02166892,NON_RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091410,NCT01933308,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,SINGLE,,,False,False,False,True
93091411,NCT05706311,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,This is a type-1 cluster 2-arm randomized trial. Randomization will take place at the pharmacy level and will be stratified by zip code level of poverty and pharmacy patient volume.,,,,
93091412,NCT02789059,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091413,NCT06063863,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091414,NCT03867422,,,COHORT,,PROSPECTIVE,,,,,,,
93091415,NCT00230646,RANDOMIZED,PARALLEL,,,,SINGLE,,,False,False,False,True
93091416,NCT02838108,,,COHORT,,PROSPECTIVE,,,,,,,
93091417,NCT00169663,,,COHORT,,RETROSPECTIVE,,,,,,,
93091418,NCT03223402,NA,SINGLE_GROUP,,TREATMENT,,NONE,,"Pilot study, one arm. We do not evaluate a specific drug. It is an Evaluation of a combination with just two instead of three drugs for the Treatment of HIV",,,,
93091419,NCT01021735,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091420,NCT00586859,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091421,NCT06350188,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,False,False,True,True
93307339,NCT02830282,,,COHORT,,PROSPECTIVE,,,,,,,
93307340,NCT06119152,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93307341,NCT02802397,NON_RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93307342,NCT00501683,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307343,NCT05735665,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93091422,NCT03741465,RANDOMIZED,SEQUENTIAL,,OTHER,,SINGLE,The ultrasonography was made by a consultant radiologist (M.D.) Although the consultant didn't know which position was for control and which was the one the study evaluates. Although investigators were trying to mask the outcomes assessor; the consultant saw the positions because there is no way to hide the sitting positions of the participants. So there is a paradox if the consultant is masked or not.,"Systematic randomization was made from 150 volunteers, and 50 participants were chosen.

All 50 participants were planned to sit on the stretcher in both of the two positioning techniques sequentially (one after another). The two positioning techniques are 1) sitting fetal position-"" the SFP"" ( a traditional position ) and 2) sitting fetal cross-legged-"" the ASP"" ( a new position, named as "" Anatolian sitting position""). The investigator was planned to record all of the participants' anatomical measurements in both of those positioning techniques evaluated via ultrasonography. After each position participants were planned to evaluate each positioning technique's comfort by 5-point numerical rating scale from minimum 1 meaning ""poor"" to maximum 5 meaning ""excellent.""",False,False,False,True
93091423,NCT03258307,NON_RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,DOUBLE,,,True,False,True,False
93091424,NCT01216202,,,COHORT,,PROSPECTIVE,,,,,,,
93091425,NCT00120016,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091426,NCT06034288,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93091427,NCT03408197,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,,,True,False,False,False
93091428,NCT05202418,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93091429,NCT03748966,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,Adults or children (age 3-17) with X-linked hypophosphatemia (XLH) will be enrolled the study. All research subjects will be treated with optimized doses of calcitriol alone (without phosphate supplementation) for one year.,,,,
93091430,NCT02098330,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091431,NCT06020898,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93091432,NCT04437901,,,COHORT,,OTHER,,,,,,,
93091433,NCT01450501,,,COHORT,,PROSPECTIVE,,,,,,,
93091434,NCT02851303,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091435,NCT02753946,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091436,NCT01521130,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091437,NCT03546621,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,"Multicenter, Open-label, Randomized",,,,
93091438,NCT04024358,,,OTHER,,OTHER,,,,,,,
93091439,NCT02572323,RANDOMIZED,CROSSOVER,,TREATMENT,,SINGLE,,,False,False,False,True
93091440,NCT02313701,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,DOUBLE,,,True,False,True,False
93091441,NCT02246725,,,OTHER,,PROSPECTIVE,,,,,,,
93091442,NCT04968158,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091443,NCT01454596,NON_RANDOMIZED,SEQUENTIAL,,TREATMENT,,NONE,,,,,,
93091444,NCT02777658,,,COHORT,,PROSPECTIVE,,,,,,,
93091445,NCT06262789,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93091446,NCT01096836,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091447,NCT04907981,,,CASE_CONTROL,,OTHER,,,,,,,
93091448,NCT00226590,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091449,NCT05055544,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,"This is a randomized, controlled, double-blinded, two-armed multicentre trial.",True,True,True,True
93091450,NCT00128739,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,DOUBLE,,,,,,
93091451,NCT06136429,NA,SINGLE_GROUP,,TREATMENT,,NONE,,"The transcatheter aortic valve system consists of 7 parts, namely the valve, the delivery system, the catheter sheath, the exchange system, the recovery system, the development exchange solution, and the curing agent.",,,,
93091452,NCT02828735,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93091453,NCT00230126,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091454,NCT06379165,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091455,NCT04836585,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,DOUBLE,The RA randomizing the participant will be not be blinded to the treatment allocation because they have to inform the provider of the treatment allocation. This RA will not be collecting outcome measures. The RA collecting outcome measures will be blinded to the treatment allocation.,,False,False,True,True
93091456,NCT01671163,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091457,NCT05183945,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091458,NCT05806463,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,SINGLE,"Participants will not be fully blinded to whether participants are in an intervention or control cluster. However, the use of a cluster-randomized approach reduces the risk of contamination among women from different clusters because it reduces the risk of communication between individuals in intervention and control arms. As HEWs will be responsible for assisting with recruitment of participants, HEWs will be aware of these eligibility criteria and who has been recruited for the study in both the control and intervention arms. As a result, HEWs will not be fully blinded to the study. Outcome assessors and statisticians will be blinded.","This is a cluster-randomized parallel intervention study model.

Following random assignment of clusters to either the intervention or control arm and subsequent recruitment of participants, individuals will be enrolled in the study.

Intervention arm: Mother's Time intervention Control arm: Standard of care

Clusters will be randomly assigned using a random number generator to either the intervention arm or the control arm. Then, all individuals recruited within a given cluster will be assigned to the same intervention condition.

Anticipating that the Mother's Time intervention will be superior to the standard care with respect to reducing symptoms of stress, depression, and anxiety and increasing modern contraceptive use, women in the control group will have opportunity to receive the full intervention upon completion of the intervention to the intervention group.",False,False,False,True
93091459,NCT00982735,,,COHORT,,PROSPECTIVE,,,,,,,
93091460,NCT04924335,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93091461,NCT04954508,,,OTHER,,PROSPECTIVE,,,,,,,
93091462,NCT04502537,,,COHORT,,PROSPECTIVE,,,,,,,
93091463,NCT05239481,RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93091464,NCT03367728,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091465,NCT00408850,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091466,NCT04757493,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,"Participant, care provider and primary outcome assessor will unaware about the allocated treatment.","Its a randomized placebo controlled parallel group clinical trial. Prucalopride group is designated as ""A"" and placebo group is designated as group ""B"".",True,True,False,True
93307344,NCT02031536,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,True,True,False
93307345,NCT01508338,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,DOUBLE,,,True,False,True,False
93091467,NCT03476200,NON_RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,NONE,,,,,,
93091468,NCT02787395,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091469,NCT00934453,RANDOMIZED,PARALLEL,,,,TRIPLE,,,True,True,True,False
93091470,NCT02714192,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,NONE,,,,,,
93091471,NCT00614380,,,,TREATMENT,,,,,,,,
93091472,NCT02161796,RANDOMIZED,CROSSOVER,,BASIC_SCIENCE,,TRIPLE,,,True,True,True,False
93091473,NCT02888106,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,"Multicenter, Open-label, Randomized, Comparative, parallel-arm phase II study",,,,
93091474,NCT05083689,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,True,False,False
93523508,NCT04378959,RANDOMIZED,CROSSOVER,,TREATMENT,,QUADRUPLE,"Identical lidocaine and placebo patches will be provided to research pharmacies at participating sites, along with site-specific randomization tables. Care providers, investigators, patients and outcome assessors will all be blinded to treatment allocation.","4 week treatment periods, separated by a 1 to 3 week washout period",True,True,True,True
93523509,NCT05463900,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93523510,NCT01971333,,,COHORT,,PROSPECTIVE,,,,,,,
93523511,NCT00771264,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93523512,NCT04405284,,,COHORT,,RETROSPECTIVE,,,,,,,
93523513,NCT00322361,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,True,False
93523514,NCT03027440,,,COHORT,,RETROSPECTIVE,,,,,,,
93523515,NCT06101784,RANDOMIZED,SEQUENTIAL,,TREATMENT,,QUADRUPLE,Double blind,"Double-Blind, Placebo-Controlled, Randomized, Adaptive, First-in-Human Study, Single and Multiple Ascending Oral Doses",True,True,True,True
93523516,NCT03961854,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,,"A randomized, double-blinded, placebo-controlled clinical trial will be carried out with children and adolescents (8-less than 18 years old) with T1D",True,True,True,True
93523517,NCT05941442,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93523518,NCT05756894,NA,SINGLE_GROUP,,TREATMENT,,NONE,,"Participants with high cervical spinal cord injury will receive 40 treatment sessions (STDP stimulation and respiratory training) and will be asked to complete pre-, Post-20, and Post-40 assessment sessions.",,,,
93523519,NCT05359250,,,COHORT,,PROSPECTIVE,,,,,,,
93523520,NCT06331871,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,70 patients with shoulder pain undergoing arthroscopic surgery were recruited. They were divided into two groups at random; physiotherapy protocol group (n=35) and experimental group to which the same protocol was practiced and two sessions of ultrasound-guided percutaneous nerve stimulation (US-PENS) were added (n=35).,,,,
93523521,NCT06162169,NON_RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93523522,NCT04783220,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,SINGLE,,,False,False,False,True
93523523,NCT04303364,,,COHORT,,PROSPECTIVE,,,,,,,
93523524,NCT04481581,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,"In this study providers cannot be masked, outcome assessors and investigators will be blinded","This will be a parallel design, unblinded, randomized (1:1) trial",False,False,True,True
93523525,NCT04484272,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93523526,NCT06409468,NA,SINGLE_GROUP,,TREATMENT,,NONE,,Case series,,,,
93523527,NCT04542499,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93523528,NCT00097994,,,COHORT,,PROSPECTIVE,,,,,,,
93523529,NCT02539966,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087034,NCT00104650,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93087035,NCT02727907,RANDOMIZED,PARALLEL,,OTHER,,QUADRUPLE,,,True,True,True,True
93087036,NCT00982826,RANDOMIZED,PARALLEL,,,,DOUBLE,,,True,False,True,False
93087037,NCT00806039,NON_RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93087038,NCT03507205,,,COHORT,,PROSPECTIVE,,,,,,,
93087039,NCT00644020,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93087040,NCT00135317,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93087041,NCT05820854,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93087042,NCT04728386,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,True,False,False,True
93087043,NCT05567250,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93087044,NCT02426736,RANDOMIZED,FACTORIAL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93087045,NCT04811846,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,"Pilot trial with parallel group design and comparison of 2 established techniques (TURBT, PKVB)",,,,
93087046,NCT03360643,RANDOMIZED,PARALLEL,,DIAGNOSTIC,,NONE,,,,,,
93087047,NCT00652795,RANDOMIZED,CROSSOVER,,,,NONE,,,,,,
93087048,NCT00369577,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93087049,NCT05990634,NA,SINGLE_GROUP,,SUPPORTIVE_CARE,,NONE,,,,,,
93087050,NCT03386721,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93087051,NCT01523418,,,COHORT,,PROSPECTIVE,,,,,,,
93087052,NCT03670563,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,Team members collecting outcomes data will not know participant allocation,Randomized controlled trial with two intervention arms and one control arm,False,False,False,True
93087053,NCT04223713,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93087054,NCT01214005,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,DOUBLE,,,True,False,False,True
93087055,NCT02552134,NON_RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93087056,NCT03948334,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93087057,NCT06500637,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93087058,NCT05825326,,,COHORT,,RETROSPECTIVE,,,,,,,
93087059,NCT02169986,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,True,False
93087060,NCT04470635,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93087061,NCT05210491,NON_RANDOMIZED,SINGLE_GROUP,,BASIC_SCIENCE,,NONE,,,,,,
93087062,NCT02766868,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087063,NCT03564613,,,COHORT,,PROSPECTIVE,,,,,,,
93087064,NCT00497757,NA,SINGLE_GROUP,,TREATMENT,,NONE,,Open label,,,,
93087065,NCT03796065,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,The Research Assistants (RAs) who will collect both qualitative and quantitative data will be blind to the condition in which study participants are randomized.,The investigators will conduct a Randomized Controlled Trial among Somali Bantu and Bhutanese families (N=300; 150 per group). Half of the families will be randomized to receive the FSI-R and half will be randomized to the control condition where the participants will receive Treatment as Usual (TAU).,False,True,False,False
93087066,NCT00239733,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93087067,NCT02538042,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,NONE,,,,,,
93087068,NCT02842294,,,COHORT,,PROSPECTIVE,,,,,,,
93414954,NCT04805242,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,False,False,True,True
93414955,NCT03582254,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93414956,NCT06187454,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,True,False
93414957,NCT00283153,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93414958,NCT04809415,RANDOMIZED,PARALLEL,,OTHER,,TRIPLE,,,True,False,True,True
93414959,NCT03131856,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,Eligible patients were randomized to either the intervention group or control group.,,,,
93414960,NCT01539473,RANDOMIZED,SINGLE_GROUP,,,,DOUBLE,,,True,False,True,False
93414961,NCT05106101,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414962,NCT05543980,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93414963,NCT02008162,,,COHORT,,PROSPECTIVE,,,,,,,
93414964,NCT02844829,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93414965,NCT01966029,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414966,NCT00387829,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93414967,NCT03999203,NON_RANDOMIZED,SINGLE_GROUP,,OTHER,,NONE,,,,,,
93414968,NCT04392531,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414969,NCT03539666,RANDOMIZED,CROSSOVER,,SCREENING,,NONE,,,,,,
93414970,NCT04344431,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93414971,NCT04790682,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93414972,NCT03354065,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,blinding of the evaluator to the study group blinding of patient to study hypothesis,,True,False,True,True
93414973,NCT03852901,NA,SINGLE_GROUP,,BASIC_SCIENCE,,NONE,,,,,,
93414974,NCT00275704,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414975,NCT05471401,NA,SINGLE_GROUP,,DEVICE_FEASIBILITY,,NONE,,,,,,
93414976,NCT00182572,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,,,,
93414977,NCT01319539,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93414978,NCT02711163,RANDOMIZED,CROSSOVER,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93414979,NCT02534324,,,COHORT,,PROSPECTIVE,,,,,,,
93414980,NCT01337921,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,,,True,True,True,True
93414981,NCT01138995,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93414982,NCT05604781,,,COHORT,,PROSPECTIVE,,,,,,,
93414983,NCT01963910,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,TRIPLE,,,True,True,False,True
93414984,NCT02933333,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93523530,NCT06054061,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,"A multicenter cluster randomized clinical trial will be conducted. The trial will consist of two arms, the experimental group will receive a 15-week intervention based on the promotion of hedonic and eudaimonic well-being. The control group will remain on a waitlist with their Treatment as Usual. Participants will be recruited from centers that focus on the psychosocial rehabilitation of people diagnosed with schizophrenia spectrum, bipolar disorder, personality disorders and severe affective disorders. Random allocation to the groups will be stratified according to the typology of the center. In the event that there is only a single representative of one of the center typologies, the entire center will be assigned to one of the study conditions. Assessments will be made before the intervention (E1), immediately after the 15-week intervention period (E2) and three (E3) and six (E4) months after the end of the intervention.",,,,
93523531,NCT01374048,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93523532,NCT06213090,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93523533,NCT06284265,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,,,True,True,True,True
93523534,NCT03147079,NON_RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,Open intervention study with 2 control arms,,,,
93523535,NCT06112652,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,Quadruple,,True,True,True,True
93091475,NCT01577017,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091476,NCT00857285,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091477,NCT05770817,,,COHORT,,PROSPECTIVE,,,,,,,
93091478,NCT02993614,,,COHORT,,PROSPECTIVE,,,,,,,
93091479,NCT05821699,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091480,NCT02483806,RANDOMIZED,CROSSOVER,,DIAGNOSTIC,,DOUBLE,,,True,False,True,False
93091481,NCT00521287,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,SINGLE,,,False,False,True,False
93091482,NCT04653480,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93116908,NCT05498415,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,Participants will be randomly assigned to group A (control) or group B (treatment) but will not be told which group they are receiving.,,True,False,False,False
93116909,NCT01103024,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93414985,NCT06049511,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,The dentist who evaluated oral mucositis did not know which group the patients belonged to.,randomized controlled group,False,True,False,True
93414986,NCT01647204,NON_RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93414987,NCT06037486,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93414988,NCT00663208,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93414989,NCT06722313,NA,SINGLE_GROUP,,DIAGNOSTIC,,NONE,,,,,,
93414990,NCT02783976,,,ECOLOGIC_OR_COMMUNITY,,PROSPECTIVE,,,,,,,
93414991,NCT02430064,NA,SINGLE_GROUP,,BASIC_SCIENCE,,NONE,,,,,,
93414992,NCT02146274,,,COHORT,,PROSPECTIVE,,,,,,,
93414993,NCT03556527,,,COHORT,,RETROSPECTIVE,,,,,,,
93414994,NCT04076280,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93414995,NCT03428490,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,Eligible participants will be randomized to the Fully Integrated Treatment (FIT; N =30) or usual care in the Matrix Institute IOP (UC; N = 30).,False,False,False,True
93414996,NCT04446273,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,"Initial and outcome assessments will be administered by a well-trained and certified occupational therapist who is blinded to the group assignment, study hypotheses, and intervention of the patients.",Participants will be randomized into the proximal priority robotic priming and impairment-oriented training or the distal priority robotic priming and impairment-oriented training groups and receive 18 intervention sessions,False,False,False,True
93414997,NCT04929782,RANDOMIZED,PARALLEL,,PREVENTION,,SINGLE,The follow-up evaluations by using the modified United States Public Health Service (USPHS) criteria were completed independently by two calibrated investigators who were blinded to the groups and a forced consensus was sought in any case of disagreement.,Two intervention groups and split-mouth design,False,False,False,True
93414998,NCT04215159,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091483,NCT06055179,RANDOMIZED,PARALLEL,,PREVENTION,,QUADRUPLE,"Patients will be randomly assigned to XCHT/placebo groups, at a 1:1 ratio, using a central randomization system provided by the TCM clinical study methodology group of Guangdong Provincial Hospital of Chinese Medicine. This group is also responsible for blinding, including keeping the blinding codes, supervision, and quality control of blinding, by allocating drug codes for each patient. Investigators will dispense the drug according to the drug codes. The investigators, the study subjects, the care givers, and the outcome assessors will be blinded to the assigned group of subjects.",,True,True,True,True
93091484,NCT04061850,,,COHORT,,RETROSPECTIVE,,,,,,,
93091485,NCT03669614,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,This is a standard double-blind randomized controlled trial.,"This study is a dose-escalation, placebo-controlled study where subjects are randomized to receive study drug or placebo.

SAD and MAD HV Phases: The HV SAD and MAD will each include up to 24 adult subjects in 3 groups (8 per dose group) in each the SAD and MAD phase . All subjects will be randomly assigned in a 3:1 ratio to receive a single administration of active drug (12 HVs) or placebo (4 HVs).

The CF MAD will evaluate 4 different dose levels in a total of 54 adult CF subjects (10 per dose level). The first 3 subjects (sentinel subjects) in the low, medium and high dose level will be randomly assigned at a 2:1 ratio to receive either AR-501 or placebo, for a total of 9 CF subjects. An expanded cohort will randomize 30 adult subjects at a 2:3:3:2 ratio to three doses of inhaled AR-501 or placebo. Subsequently an 80mg Ga dose (top dose) cohort will randomize subjects at a 2:1 ratio to receive either AR 501 or placebo for a total of 15 subjects , including 6 sentinel subjects.",True,True,True,True
93091486,NCT00694616,RANDOMIZED,CROSSOVER,,TREATMENT,,TRIPLE,,,True,False,True,True
93091487,NCT00804726,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091488,NCT04363203,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,QUADRUPLE,"Eligible, consented patients will be randomized to a 1:1:1 treatment allocation, stratifying by age (\<65, 65 or more) and region, and using randomly permutated blocks (block size of 3) within study site. Pharmacy is unblinded to study drugs.",A 3-arm RCT to determine the efficacy of hydroxychloroquine or azithromycin compared to placebo in treating mild to moderate COVID-19 among Veterans in the outpatient setting.,True,True,True,True
93091489,NCT03865446,NON_RANDOMIZED,PARALLEL,,OTHER,,NONE,,,,,,
93091490,NCT04818658,,,COHORT,,OTHER,,,,,,,
93091491,NCT00976131,RANDOMIZED,CROSSOVER,,SUPPORTIVE_CARE,,TRIPLE,,,True,True,True,False
93091492,NCT03944928,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091493,NCT00531765,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091494,NCT03735836,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,NONE,,Randomized study with two parallel treatment arms.,,,,
93091495,NCT03273426,NON_RANDOMIZED,PARALLEL,,DIAGNOSTIC,,NONE,,Comparison of pathological findings for residual tumor between minimally-invasive biopsy procedure and subsequent wide excision of the biopsied area,,,,
93091496,NCT05313113,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93091497,NCT00871767,RANDOMIZED,CROSSOVER,,,,NONE,,,,,,
93091498,NCT01152658,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93091499,NCT03379220,,,COHORT,,PROSPECTIVE,,,,,,,
93091500,NCT03566342,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93091501,NCT01792700,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091502,NCT01145742,RANDOMIZED,SINGLE_GROUP,,HEALTH_SERVICES_RESEARCH,,,,,,,,
93091503,NCT05221060,,,ECOLOGIC_OR_COMMUNITY,,CROSS_SECTIONAL,,,,,,,
93091504,NCT00361673,,,,,CROSS_SECTIONAL,,,,,,,
93091505,NCT03585478,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93091506,NCT03071263,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091507,NCT03360123,RANDOMIZED,CROSSOVER,,OTHER,,NONE,,,,,,
93091508,NCT06173414,,,OTHER,,PROSPECTIVE,,,,,,,
93091509,NCT00549315,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091510,NCT05089799,,,CASE_ONLY,,CROSS_SECTIONAL,,,,,,,
93091511,NCT06262893,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,True,False
93091512,NCT05355064,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091513,NCT02108249,,,COHORT,,OTHER,,,,,,,
93091514,NCT05863884,NA,SINGLE_GROUP,,PREVENTION,,NONE,,,,,,
93091515,NCT06155422,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93091516,NCT05893095,,,OTHER,,RETROSPECTIVE,,,,,,,
93307346,NCT04910633,,,CASE_ONLY,,RETROSPECTIVE,,,,,,,
93307347,NCT02853487,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93523536,NCT05868226,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,"This is an open-label, multi-site, multi-arm platform study, where each drug regimen arm may have different study designs and eligibility. In particular, dose finding parts may employ different designs (e.g., 3+3, Bayesian Optimal Interval Design \[BOIN\], continual reassessment method \[CRM\], etc.) for each arm in the PRE-I-SPY program. See each arm for specific study model details.",,,,
93091517,NCT04662008,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,NONE,,,,,,
93307348,NCT06234553,,,COHORT,,RETROSPECTIVE,,,,,,,
93091518,NCT00005617,,,,TREATMENT,,,,,,,,
93091519,NCT03133247,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091520,NCT00001118,,,,TREATMENT,,,,,,,,
93091521,NCT01785888,,,COHORT,,PROSPECTIVE,,,,,,,
93307349,NCT04530578,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,"Controled, prospective, randomized, comparative against standard treatment.",,,,
93307350,NCT06028490,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307351,NCT06370442,RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,DOUBLE,,,True,True,False,False
93307352,NCT01115608,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,NONE,,,,,,
93307353,NCT01850030,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307354,NCT05260593,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93091522,NCT00876616,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091523,NCT00360412,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091524,NCT03318588,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93116910,NCT01156064,,,CASE_CONTROL,,PROSPECTIVE,,,,,,,
93116911,NCT00912236,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93116912,NCT01696929,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93116913,NCT04137445,RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,DOUBLE,,,True,True,False,False
93523537,NCT06022042,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,"This study takes a single-blind method. During research process, the researchers cannot avoid knowing the type of abutment used by the subjects during the clinical examination and operation, so the subjects can only be single-blinded.The clinical examination data were measured and averaged by two independent clinicians. The data was analysed by a third person.","The researchers prospectively and continuously recruited subjects who underwent implant therapy in the Oral Implantation Center of the Stomatology Hospital Affiliated to Zhejiang University School of Medicine, and all subjects who signed written informed consent were divided into 8 groups by random number table method: â  On1 abutment + Nobel Replace Conical Connection PMC implant group (hereinafter referred to as Nobel PMC), â¡On1 abutment + Nobel Parallelâ¢ Conical Connection implant group (hereinafter referred to as Nobel PCC), â¢On1 abutment + Nobel Replace Conical Connection implant group (Hereinafter referred to as Nobel CC), â£ One-stage abutment + Nobel PMC implant set, â¤ One-stage abutment + Nobel PCC implant set, â¥ One-stage abutment + Nobel CC implant set.",True,True,False,True
93091525,NCT03823183,RANDOMIZED,FACTORIAL,,BASIC_SCIENCE,,SINGLE,,"This study includes 4 intervention conditions: (1) Multi-modal Cognitive intervention + Physical intervention, (2) Cognitive intervention + Physical control, (3) Physical intervention + Cognitive control, and (4) Active Control group, Cognitive control + Physical control) x 3 (Time: Pretest, Post-test, 3-month follow-up) mixed factorial design, with ""Type of training"" as between-subject factors and ""Time"" as within-subject factor. The dependent variables will be behavioral and/or electrophysiological measures of executive functions (inhibition, shifting, working memory), memory functions (short term, episodic memory), and emotional well-being, quality of live and motivation.",True,False,False,False
93091526,NCT02840708,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091527,NCT02356913,RANDOMIZED,CROSSOVER,,TREATMENT,,NONE,,,,,,
93091528,NCT03082248,NON_RANDOMIZED,SINGLE_GROUP,,OTHER,,NONE,,,,,,
93091529,NCT03212898,RANDOMIZED,PARALLEL,,HEALTH_SERVICES_RESEARCH,,DOUBLE,,,True,True,False,False
93091530,NCT06313229,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,The present clinical trial was single-blinded one as the evaluator and the statistician were both blinded. While both the implantologist or the participant were not blinded as the interventions were dissimilar.,"single-center, prospective, single-blinded, randomized parallel two-arm controlled clinical trial",True,False,False,True
93091531,NCT00001114,,,,TREATMENT,,,,,,,,
93523538,NCT04498000,,,COHORT,,PROSPECTIVE,,,,,,,
93091532,NCT05301517,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091533,NCT01381393,,,COHORT,,PROSPECTIVE,,,,,,,
93091534,NCT02952885,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091535,NCT03549221,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,False,True
93091536,NCT05706779,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091537,NCT06484244,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93091538,NCT04508049,NA,SINGLE_GROUP,,SCREENING,,NONE,,,,,,
93091539,NCT06212297,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93091540,NCT05755438,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93091541,NCT05332275,RANDOMIZED,PARALLEL,,PREVENTION,,NONE,,,,,,
93091542,NCT03095248,NON_RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,All participants with neurofibromatosis type 2 (NF2) will be stratified based upon tumor type. Vestibular schwannomas are assigned and analyzed as Stratum 1 and all other NF2 associated tumor types will be analyzed as Stratum 2.,,,,
93091543,NCT06148597,,,COHORT,,PROSPECTIVE,,,,,,,
93091544,NCT05931367,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,,,True,False,True,False
93307355,NCT00136370,RANDOMIZED,PARALLEL,,PREVENTION,,DOUBLE,,,False,False,True,True
93307356,NCT04492813,NON_RANDOMIZED,PARALLEL,,BASIC_SCIENCE,,SINGLE,,"Each obese patient is matched with a non-obese patient by considering a pairing according to age (more or less 5 years), gender and renal function (more or less 10ml / min / 1.73mÂ² creatinine clearance).",False,False,False,True
93307357,NCT04160806,RANDOMIZED,PARALLEL,,TREATMENT,,TRIPLE,,,True,False,True,True
93307358,NCT00905047,RANDOMIZED,CROSSOVER,,TREATMENT,,NONE,,,,,,
93523539,NCT00514787,,,CASE_ONLY,,PROSPECTIVE,,,,,,,
93523540,NCT05350553,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93523541,NCT01848236,RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93116914,NCT03165604,RANDOMIZED,PARALLEL,,TREATMENT,,DOUBLE,Subjects will be given the same drink (water) in different packaging,,True,True,False,False
93307359,NCT04627415,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,False,False,False,True
93307360,NCT04767724,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307361,NCT04201899,,,COHORT,,PROSPECTIVE,,,,,,,
93307362,NCT01984437,,,COHORT,,PROSPECTIVE,,,,,,,
93307363,NCT04330651,,,COHORT,,PROSPECTIVE,,,,,,,
93307364,NCT01807429,RANDOMIZED,PARALLEL,,TREATMENT,,SINGLE,,,True,False,False,False
93307365,NCT02688530,RANDOMIZED,PARALLEL,,OTHER,,QUADRUPLE,,,True,True,True,True
93307366,NCT04258657,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307367,NCT04367207,,,COHORT,,PROSPECTIVE,,,,,,,
93307368,NCT06348264,NA,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307369,NCT02554383,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307370,NCT03772093,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307371,NCT05495698,RANDOMIZED,PARALLEL,,OTHER,,NONE,,"The first group will receive multi-inhaler triple therapy (control group), the second group single inhaler triple therapy (intervention group 1) and the third group single inhaler triple therapy with extra digital support to increase therapy adherence (intervention group 2).",,,,
93307372,NCT00724386,NON_RANDOMIZED,SINGLE_GROUP,,TREATMENT,,NONE,,,,,,
93307373,NCT03318653,,,COHORT,,CROSS_SECTIONAL,,,,,,,
93307374,NCT03448536,RANDOMIZED,CROSSOVER,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307375,NCT05006222,NON_RANDOMIZED,PARALLEL,,SUPPORTIVE_CARE,,DOUBLE,,,True,False,True,False
93307376,NCT03575676,RANDOMIZED,CROSSOVER,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307377,NCT04016116,RANDOMIZED,PARALLEL,,TREATMENT,,NONE,,,,,,
93307378,NCT02788071,RANDOMIZED,PARALLEL,,TREATMENT,,QUADRUPLE,,,True,True,True,True
93307379,NCT01056263,,,,,RETROSPECTIVE,,,,,,,
93307380,NCT01002716,NON_RANDOMIZED,SINGLE_GROUP,,PREVENTION,,NONE,,,,,,
